These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25937441)

  • 41. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
    Zhang B; Sun XJ; Ju CH
    Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Desmoteplase in the treatment of acute ischemic stroke.
    Dafer RM; Biller J
    Expert Rev Neurother; 2007 Apr; 7(4):333-7. PubMed ID: 17425487
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Controversies section: introduction.
    Blackham KA
    J Neurointerv Surg; 2012 May; 4(3):163. PubMed ID: 22491509
    [No Abstract]   [Full Text] [Related]  

  • 44. Letter by Scheitz et al regarding article, "Intravenous thrombolysis in nonagenarians with ischemic stroke".
    Scheitz JF; Audebert HJ; Nolte CH
    Stroke; 2011 Oct; 42(10):e563; author reply e564. PubMed ID: 21921275
    [No Abstract]   [Full Text] [Related]  

  • 45. Complete recovery following intra-arterial tenecteplase administration in a woman with acute ischemic stroke.
    Meenakshi-Sundaram S; Periakaruppan A; Karuppiah SN; Karthik SN; Roopakumar L; Thembavani I
    J Clin Neurosci; 2013 Dec; 20(12):1786-8. PubMed ID: 23938013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combining antithrombotic and fibrinolytic agents: can it be done?
    Khatri P; Mono ML
    Stroke; 2013 May; 44(5):1489-91. PubMed ID: 23559267
    [No Abstract]   [Full Text] [Related]  

  • 47. Medical therapy for ischemic stroke: review of intravenous and intra-arterial treatment options.
    Taussky P; Tawk RG; Daugherty WP; Hanel RA
    World Neurosurg; 2011 Dec; 76(6 Suppl):S9-15. PubMed ID: 22182278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of acute ischemic stroke, Part 1.
    Fullerton T
    J Am Pharm Assoc (Wash); 1996 Oct; NS36(10):571-2. PubMed ID: 8908931
    [No Abstract]   [Full Text] [Related]  

  • 49. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke in a patient treated with rivaroxaban.
    van Hooff RJ; Nieboer K; De Smedt A; Yperzeele L; Jochmans K; De Keyser J; Brouns R
    Clin Neurol Neurosurg; 2014 Jul; 122():133-4. PubMed ID: 24813326
    [No Abstract]   [Full Text] [Related]  

  • 50. Inhibition of desmoteplase-induced fibrinolytic activity in vitro.
    Hoffmann JJ; Kops O
    J Thromb Thrombolysis; 2005 Aug; 20(1):23-6. PubMed ID: 16133891
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intra-arterial thrombolysis in acute ischaemic stroke.
    Jones MM; Nogajski JH; Faulder K; Harrington T; Ng P; Storey CE
    Intern Med J; 2005 May; 35(5):300-2. PubMed ID: 15845114
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Desmoteplase in Acute Ischemic Stroke (DIAS) clinical trial program.
    von Kummer R; Albers GW; Mori E;
    Int J Stroke; 2012 Oct; 7(7):589-96. PubMed ID: 22989394
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
    Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
    J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Thrombolytic therapy with tPA for the treatment of acute stroke. The Standard Treatment with Alteplase to Reverse Stroke study].
    Di Pasquale G
    Ital Heart J Suppl; 2000 Jul; 1(7):947-8. PubMed ID: 10935744
    [No Abstract]   [Full Text] [Related]  

  • 55. Refinement of the magnetic resonance diffusion-perfusion mismatch concept for thrombolytic patient selection: insights from the desmoteplase in acute stroke trials.
    Warach S; Al-Rawi Y; Furlan AJ; Fiebach JB; Wintermark M; Lindstén A; Smyej J; Bharucha DB; Pedraza S; Rowley HA
    Stroke; 2012 Sep; 43(9):2313-8. PubMed ID: 22738918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of a combined intravenous/intra-arterial approach in octogenarians.
    Mazighi M; Labreuche J; Meseguer E; Serfaty JM; Laissy JP; Lavallée PC; Cabrejo L; Guidoux C; Lapergue B; Klein IF; Olivot JM; Abboud H; Simon O; Schouman-Claeys E; Amarenco P
    Cerebrovasc Dis; 2011; 31(6):559-65. PubMed ID: 21487220
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Response to Letter Regarding Article, "Relevance of Blood-Brain Barrier Disruption After Endovascular Treatment of Ischemic Stroke: Dual-Energy Computed Tomographic Study".
    Renú A; Amaro S; Chamorro Á
    Stroke; 2015 Aug; 46(8):e200. PubMed ID: 26111892
    [No Abstract]   [Full Text] [Related]  

  • 58. Efficacy of telemedicine for thrombolytic therapy in acute ischemic stroke: a meta-analysis.
    Zhai YK; Zhu WJ; Hou HL; Sun DX; Zhao J
    J Telemed Telecare; 2015 Apr; 21(3):123-30. PubMed ID: 25670675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Letter by Bosche and Macdonald regarding article, "relevance of blood-brain barrier disruption after endovascular treatment of ischemic stroke: dual-energy computed tomographic study".
    Bosche B; Macdonald RL
    Stroke; 2015 May; 46(5):e126-7. PubMed ID: 25873599
    [No Abstract]   [Full Text] [Related]  

  • 60. Thrombolysis after stroke.
    Fieschi C; Toni D
    Lancet; 1996 Oct; 348(9033):1035. PubMed ID: 8855886
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.